Join
Live feed
·
PRReleasevia Quantisnow
Liminatus Pharma Inc. logo

Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline

ByQuantisnow·Wall Street's wire, on your screen.
LIMN· Liminatus Pharma Inc.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIMN (Liminatus Pharma Inc.) and more on Quantisnow.